B cells play a central role in adaptive immunity and are important therapeutic targets in autoimmune disease, inflammation and oncology. ICE Bioscience provides in vitro B cell assay services that evaluate B cell activation, proliferation, differentiation and antibody production, supporting immunology drug discovery programs.
B cell assays are widely used to profile immunosuppressive and immunomodulatory compounds, evaluate antibody-based therapeutics and investigate mechanisms of action in autoimmune and inflammatory disease models. Assays can be customized to specific project needs, including compound screening and dose-response profiling.
B cell assays at ICE Bioscience are part of a comprehensive in vitro immunology platform that also includes T cell, NK cell, dendritic cell and macrophage assays, enabling multi-lineage immune profiling within a single project.
If you would like to learn more about this service or discuss your project, please contact our team for a tailored proposal and quotation.
We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Get a quote
Go top